Tumor-based rhythms of anticancer efficacy in experimental models

REFERENCES

• Scheving L.E. Chronobiology of Cell Proliferation in Mammals: Implications for Basic Research and Cancer Chemotherapy. Cell Cycle Clocks. Marcel Dekker, New York 1984; 455–499
   Google Scholar
• Bjarnason G.A., Jordan R. Circadian Variation of Cell Proliferation and Cell Cycle Protein Expression in Man: Clinical Implications. Progress in Cell Cycle Research, L. Meijer, A. Jezequel, B. Ducommun. Kluwer Academic/Plenum Publishers, New York 2000; 193–206
   Google Scholar
• Lincoln D.W., Hrushesky W.J.M., Wood P.A. Circadian Organization of Thymidylate Synthase Activity in Normal Tissues: A Possible Basis for 5-Fluorouracil Chronotherapeutic Advantage. Int. J. Cancer 2000; 88: 479–485
   PubMed Web of Science ®Google Scholar
• Pinedo H., Peters G. 5-Fluorouracil: Biochemistry and Pharmacology. J. Clin. Oncol. 1988; 6: 1653–1664
   PubMed Web of Science ®Google Scholar
• Tampellini M., Filipski E., Liu X.H., Lemaigre G., Li X.M., Vrignaud P., Francois E., Bissery M.C., Levi F. Docetaxel Chronopharmacology in Mice. Cancer Res. 1998; 58: 3896–3904
   PubMed Web of Science ®Google Scholar
• Liu X.H., Metzger G., Levi F. Circadian Rhythms in Bcl-2 and Bax Protein Expressions in Mouse Bone Marrow. Proceedings of the 92nd Annual Meeting of the AACR. American Association for Cancer Research, Philadelphia 2001; Vol. 42: 305–306
   Google Scholar
• Mormont M.C., Levi F. Circadian-System Alterations During Cancer Processes: A Review. Int. J. Cancer 1997; 70: 241–247
   PubMed Web of Science ®Google Scholar
• Focan C. Circadian Rhythms and Cancer Chemotherapy. Pharmacol. Ther. 1995; 67(1)1–52
   PubMed Web of Science ®Google Scholar
• Granda T.G., Liu X.H., Filipski E., Vrignaud P., Bissery M.C., Levi F. Different Rhythms in Cell Cycle Distribution in Bone Marrow and in MA13/C Mammary Tumor of C3H/HeN Mice. Proceedings of the 92nd Annual Meeting of the AACR. American Association for Cancer Research, Philadelphia 2001; Vol. 42: 912
   Google Scholar
• Voutilainen A. Uber die 24-Stunden-Rhythmik der Mitozfrequenz in Malignen Tumoren. Acta Pathol. Microbiol. Scand. 1953; 99(1)1–104
   Google Scholar
• Tahti E. Studies of the Effect of X-Irradiation on 24 hour Variations in the Mitotic Activity in Human Malignant Tumors. Acta Pathol. Microbiol. Scand. 1956; 117: 1–61
   Google Scholar
• Klevecz R.R., Shymko R.M., Blumenfeld D., Braly P.S. Circadian Gating of S Phase in Human Ovarian Cancer. Cancer Res. 1987; 47(23)6267–6271
   PubMed Web of Science ®Google Scholar
• Klevecz R.R., Braly P.S. Circadian and Ultradian Cytokinetic Rhythms of Spontaneous Human Cancer. Ann. NY Acad. Sci. 1991; 618: 257–276
   PubMed Web of Science ®Google Scholar
• Smaaland R., Lote K., Sothern R.B., Laerum O.D. DNA Synthesis and Ploidy in Non-Hodgkin's Lymphomas Demonstrate Intrapatient Variation Depending on Circadian Stage of Cell Sampling. Cancer Res. 1993; 53: 3129–3138
   PubMed Web of Science ®Google Scholar
• Hrushesky W.J.M., Lannin D., Haus E. Evidence for an Ontogenetic Basis for Circadian Coordination of Cancer Cell Proliferation. J. Natl Cancer Inst. 1998; 90(19)1480–1484
   PubMedGoogle Scholar
• Burns E.R., Scheving L.E., Tsai T.H. Circadian Rhythms in DNA Synthesis and Mitosis in Normal Mice and in Mice Bearing a Lewis Lung Carcinoma. Eur. J. Cancer 1979; 15: 233–242
   PubMed Web of Science ®Google Scholar
• Barbason H., Betz E.H. Liver-Cell Control After Discontinuation of DENA Feeding in Hepatocarcinogenesis. Eur. J. Cancer 1980; 17: 149–156
   Google Scholar
• Kampfschmidt R.F., Upchurch H.F. Daily Variation of Body Temperature, Liver Catalase Activity, and Plasma Iron Concentration in Normal and Tumor-Bearing Rats. Proc. Soc. Exp. Biol. Med. 1970; 134: 527–529
   PubMedGoogle Scholar
• Barbason H., De Paermentier F., Van Canfort J. Molecular Regulatory Mechanisms of Nycthemeral Rhythms in Hepatic-Cell Division and Function. Animal and Environmental Fitness, R. Gilles. Pergamon Press, New York 1980; 145–162
   Google Scholar
• Kishimoto R., Terasawa K., Sakamoto Y., Nakata Y. Shift of Circadian Metabolic Rhythm in BFO-Osteosarcoma-Bearing Mice. Jpn. J. Cancer Res. 1985; 76: 284–288
   PubMedGoogle Scholar
• Sothern R.B., Hrushesky W.J.M., Halberg F., Haus E., Kennedy B.J. Circadian Temperature Rhythm in LOU Rats with and without Immunocytoma During Polychronochemotherapy with Adriamycin and Cisdiamminedichloroplatinum. Chronobiologia 1978; 5: 216
   Google Scholar
• Potter V.R., Watanabe M., Pitot H.C., Morris H.P. Systematic Oscillations in Metabolic Activity in Rat Liver And Hepatomas. Survey of Normal Diploid and Another Hepatoma Lines. Cancer Res. 1969; 29: 55–78
   PubMedGoogle Scholar
• Bouzahzah B. Influence de Differents Promoteurs sur la Proliferation Cellulaire du Foie de Rat Normal et Precancereux: Role des Corticoides et des Rythmes Circadiens. University of Liege
   Google Scholar
• Hrushesky W.J.M., Haus E., Lakatua D.J., Halberg F., Langevin T.R., Kennedy B.J. Marker Rhythms for Cancer Chrono-chemotherapy. Chronobiology 1982–1983, E. Haus, H. Kabat. Karger, Basel 1984; 493–499
   Google Scholar
• Benavides M. Cancer Avance de l'ovaire: Approche Chronobiologique Comme Nouvelle Strategie du Traitement et de la Surveillance Clinique et Biologique. University of Paris
   Google Scholar
• Touitou Y., Levi F., Bogdan A., Benavides M., Bailleul F., Misset J.L. Rhythm Alteration in Patients with Metastatic Breast Cancer and Poor Prognostic Factors. J. Cancer Res. Clin. Oncol. 1995; 121: 181–188
   PubMed Web of Science ®Google Scholar
• Bartsch C., Bartsch H., Bellmann O., Lippert T.H. Depression of Serum Melatonin in Patients with Primary Breast Cancer Is Not Due to an Increased Peripheral Metabolism. Cancer 1991; 61: 1681–1684
   Google Scholar
• Bartsch C., Bartsch H., Fluchter S.H., Mecke D., Lippert T.H. Diminished Pineal Function Coincides with Disturbed Circadian Endocrine Rhythmicity in Untreated Primary Cancer Patients. Ann. NY Acad. Sci. 1994; 719: 502–525
   PubMed Web of Science ®Google Scholar
• Tamarkin L., Danforth D., Lichter A., De Moss E., Cohen M., Chabner B., Lippman M. Decreased Nocturnal Plasma Melatonin Peak in Patients with Estrogen-Receptor-Positive Breast Cancer. Science 1982; 216: 1003–1005
   PubMed Web of Science ®Google Scholar
• Sephton S.E., Sapolsky R.M., Kraemer H.C., Spiegel D. Diurnal Cortisol Rhythm as a Predictor of Breast Cancer Survival. J. Natl Cancer Inst. 2000; 92(12)994–1000
   PubMedGoogle Scholar
• Mormont M.C., Waterhouse J., Bleuzen P., Giacchetti S., Jami A., Bogdan A., Lellouch J., Misset J.L., Touitou Y., Levi F. Marked 24-h Rest/Activity Rhythms Are Associated with Better Quality of Life, Better Response, and Longer Survival in Patients with Metastatic Colorectal Cancer and Good Performance Status. Clin. Cancer Res. 2000; 6: 3038–3045
   PubMed Web of Science ®Google Scholar
• Granda T.G., Filipski E., D'Attino R.M., Vrignaud P., Anjo A., Bissery M.C., Levi F. Experimental Chronotherapy of Mouse Mammary Adenocarcinoma MA13/C with Docetaxel and Doxorubicin as Single Agents and in Combination. Cancer Res. 2001; 61: 1996–2001
   PubMed Web of Science ®Google Scholar
• Halberg F., Haus E., Cardoso S.S., Scheving L.E., Kühl J.F.W., Shiotsuka R., Rosene G., Pauly J.E., Runge W., Spalding J.F., Lee J.K., Good R.A. Toward a Chronotherapy of Neoplasia: Tolerance of Treatment Depends upon Host Rhythms. Experientia (Basel) 1973; 29: 909–934
   PubMedGoogle Scholar
• Hori K., Zhang Q.H., Li H.C., Saito S., Sato Y. Timing of Cancer Chemotherapy Based in Circadian Variations in Tumor Tissue Blood Flow. Int. J. Cancer 1996; 65(3)360–364
   PubMedGoogle Scholar
• Levi F. Chronochimiotherapie et Intensite de Dose. Bull. Cancer 1995; 82(1)29–36
   PubMedGoogle Scholar
• Sothern R.B., Levi F., Haus E., Halberg F., Hrushesky W.J. Control of a Murine Plasmacytoma with Doxorubicin–Cisplatin: Dependence on Circadian Stage of Treatment. J. Natl Cancer Inst. 1989; 81(2)135–145
   PubMedGoogle Scholar
• Li X.M., Filipski E., Levi F. Pharmacological Modulation of Cisplatin Toxicity Rhythms with Buthionine Sulfoximine in Mice Bearing Pancreatic Adenocarcinoma (PO3). Chronobiol. Int. 1998; 15(4)323–335
   PubMed Web of Science ®Google Scholar
• Filipski E., Liu X.H., Vrignaud P., Bissery M.C., Levi F. Chronopharmacologic Optimization of Docetaxel–Doxorubicin Combination in Mice with P388 Leukemia. Proceedings of the 90th Annual Meeting AACR. American Association for Cancer Research, Philadelphia 1999; Vol. 40: 589, (Abstract 3885)
   Google Scholar
• Filipski E., Amat S., Lemaigre G., Vincenti M., Breillout F., Levi F. Relationship Between Circadian Rhythm of Vinorelbine Toxicity and Efficacy in P388-Bearing Mice. J. Pharmacol. Exp. Ther. 1999; 289: 231–235
   PubMedGoogle Scholar
• Halberg F., Nelson W., Levi F., Culley D., Bogden A., Taylor D.J. Chronotherapy of Rats Mammary Cancer. Int. J. Chronobiol. 1980; 7: 85–90
   PubMedGoogle Scholar
• Scheving L.E., Burns E.R., Pauly J.E., Halberg F. Circadian Bioperiodic Response of Mice Bearing Advanced L1210 Leukemia to Combination Therapy with Adriamycin and Cyclophosphamide. Cancer Res. 1980; 40: 1511–1515
   PubMed Web of Science ®Google Scholar
• Levi F. Chronopharmacology of Anticancer Agents. Physiology and Pharmacology of Biological Rhythms, P.H. Redfern, B. Lemmer. Springer-Verlag, Berlin 1997; 299–331
   Google Scholar
• Mormont M.C., Levi F. Cancer Medicine Update. B. C. Decker Inc., Hamilton, Ontario 2001
   Google Scholar
• Levi F. Circadian Chronotherapy for Human Cancers. Lancet Oncol. 2001; 2: 307–315
   PubMed Web of Science ®Google Scholar
• Rubin N.H., Hokanson J.A., Bogdon G. Circadian Rhythms in Phases of the Cell Cycle in the Hamster as Demonstrated by Flow Cytometry. Cell Tissue Kinet. 1983; 16: 115–123
   PubMedGoogle Scholar
• Brown W.R. A Review and Mathematical Analysis of Circadian Rhythms in Cell Proliferation in Mouse, Rat, and Human Epidermis. J. Invest. Dermatol. 1991; 97(2)273–280
   PubMed Web of Science ®Google Scholar
• Scheving L.E., Burns E.R., Pauly J.E., Tsai T.H. Circadian Variation in Cell Division of the Mouse Alimentary Tract, Bone Marrow and Corneal Epithelium. Anat. Rec. 1978; 191: 479–486
   PubMedGoogle Scholar
• Thomson P.J., McGurk M., Potten C.S., Walton G.M., Appleton D.R. Tritiated Thymidine and Bromodeoxyuridine Double-Labelling Studies on Growth Factors and Oral Epithelial Proliferation in the Mouse. Arch. Oral Biol. 1999; 44(9)721–734
   PubMedGoogle Scholar
• Garcia M.N., Barbeito C.G., Andrini L.A., Badran A.F. Circadian Rhythm of DNA Synthesis and Mitotic Activity in Tongue Keratinocytes. Cell Biol. Int. 2001; 25(2)179–183
   PubMedGoogle Scholar
• Burns E.R. Circadian Rhythmicity in DNA Synthesis in Untreated and Saline-Treated Mice as a Basis for Improved Chronochemotherapy. Cancer Res. 1981; 41(7)2795–2802
   PubMedGoogle Scholar
• Scheving L.A., Tsai T.H., Scheving L.E. Effect of Thioacetamide on the Incorporation of 3H-Thymidine into DNA of 13 Tissues and on the Mitotic Index of the Corneal Epithelium of BD2F1 in Male Mice While Taking into Consideration Circadian Variation. Chronobiol. Int. 1986; 3: 1–15
   PubMedGoogle Scholar
• Scheving L.E. Circadian Rhythms in Cell Proliferation: Their Importance When Investigating the Basic Mechanism of Normal Versus Abnormal Growth. Prog. Clin. Biol. Res. 1981; 59C: 39–79
   PubMedGoogle Scholar
• Ohdo S., Makinosumi T., Ishizaki T., Yukawa E., Higuchi S., Nakano S., Ogawa N. Cell Cycle-Dependent Chronotoxicity of Irinotecan Hydrochloride in Mice. J. Pharmacol. Exp. Ther. 1997; 283: 1383–1388
   PubMed Web of Science ®Google Scholar
• Berezkin M.V. A Comparative Study of the Circadian Rhythm of Mitotic Activity in Neoplasia and Normal Tissues. Bull. Eksp. Biol. Med. 1970; 70: 83–84
   Google Scholar
• Badran A.F., Echave Llanos J.M. Persistance of Mitotic Circadian Rhythm of a Transplantable Mammary Carcinoma After 35 Generations: Its Bearing on the Success of Treatment with Endoxan. J. Natl Cancer Inst. 1965; 35: 285–290
   PubMedGoogle Scholar
• Focan C., Schyns-Mosen J., Luyckx A., Lefebvre P. Circadian Variability of Kinetics in a Transplantable Islet Cell Tumor of the Golden Hamster. J. Cancer Res. Clin. Oncol. 1982; 104: 197–206
   PubMed Web of Science ®Google Scholar
• Focan C., Barbason H., Betz E.H. Influence du Rythme Nycthemeral des Divisions Cellulaires sur l'efficacite de la Cyclophosphamide Contre des Sarcomes Induits par le Methylcholanthrene. C. R. Acad. Sci. Paris 1973; 276: 2105–2108
   Google Scholar
• Focan C., Barbason H., Betz E.H. Evidence of a G1 Regulation of Circadian Proliferation in Mouse Methylcholantrene Induced Sarcomas. Eur. J. Cancer 1979; 15: 1371–1376
   Web of Science ®Google Scholar
• Focan C. University of Liege
   Google Scholar
• Moskalic K.G. Duration of Mitosis and Diurnal Rhythm of Cell Division in Ehrlich Tumor Lymphoma NK-Ly. Bull. Eksp. Biol. Med. 1973; 75: 99–102
   Google Scholar
• Calleja R., Herbold D., Hoppe M., Römer G., Philippens K.M.H. Circadian Rhythms in Ehrlich Ascites Tumor (EAT)-Bearing NMRI/Han Mice. Effects of Meal-Timing on Tumor and Host. Chronobiologia 1987; 14: 158
   Google Scholar
• Potter V.R. Systematic Oscillations of Metabolic Activity in Rat Liver and Hepatomas I. Morris No 7793 Hepatoma. Cancer Res. 1966; 26: 1547–1550
   PubMed Web of Science ®Google Scholar
• Nash R.E., Echave Llanos J.M. Twenty-Four-Hour Variations in DNA Synthesis of Fast-Growing and Slow-Growing Hepatoma: DNA Synthesis Rhythm in Hepatoma. J. Natl Cancer Inst. 1971; 47: 1007–1012
   PubMed Web of Science ®Google Scholar
• Sackett D. Circadian Host and Tumor Rhythms in Balb/c Mice, Rhythm Induction in Harding–Passey Melanoma. Prog. Clin. Biol. Res. 1981; 59C: 165–183
   PubMedGoogle Scholar
• Lakatua D.J., White M., Sackett-Lundeen L.L., Haus E. Change in Phase Relations of Circadian Rhythms in Cell Proliferation Induced by Time-Limited Feeding in BALB/c×DBA/2 F1 Mice Bearing a Transplantable Harding–Passey Tumor. Cancer Res. 1983; 43: 4068–4072
   PubMedGoogle Scholar
• Sokolowa I.V. Circadian Changes in Mitotic Activity and DNA Synthesis in Rat Neoplastic and Normal Tissues. Bull. Eksp. Biol. Med. 1973; 76: 64–67
   Google Scholar
• Bertalanffy F.D., Lau C. Rates of Cell Division in Transplantable Malignant Rat Tumors. Cancer Res. 1962; 22: 627–631
   PubMedGoogle Scholar
• Scheving L.E., Burns E.R., Halberg F., Pauly J.E. Combined Chronochemotherapy of L1210 Leukemic Mice Using 1-beta-d-Arabinofuranosylcytosine, Cyclophosphamide, Vincristine, Methylprednisolone and cis-Diamminedichloroplatinum. Chronobiologia 1980; 7(1)33–40
   PubMedGoogle Scholar
• D'Attino R.M., Granda T.G., Filipski E., Vrignaud P., Garufi C., Terzoli E., Bissery M.C., Lévi F. Circadian Optimization of Irinotecan and Oxaliplatin Efficacy in Mice with Glasgow Osteosarcoma. Br. J. Cancer, in press
   Google Scholar